{"DataElement":{"publicId":"2415075","version":"1","preferredName":"Growth Factor Agent Current Report Period Administered Type","preferredDefinition":"the type of growth factor administered during the current report period.","longName":"GF_AG_CU_R_P_AD_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2415068","version":"1","preferredName":"Growth Factor Agent Current Report Period Administered","preferredDefinition":"information related to the administration of growth factor, substances made by the body that function to regulate cell division and cell survival, during the current report period.","longName":"GF_AGT_CU_RE_PD_ADM","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2415066","version":"1","preferredName":"Growth Factor Agent","preferredDefinition":"Substances made by the body that function to regulate cell division and cell survival. Some growth factors are also produced in the laboratory and used in biological therapy.:An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. (NCI)","longName":"C20424:C1708","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Growth Factor","conceptCode":"C20424","definition":"Growth Factors are extracellular signaling molecules (ligands) involved in control of target cell proliferation, cell survival, and cell differentiation. (NCI)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"027804FD-E52A-104C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-07","modifiedBy":"ONEDATA","dateModified":"2005-10-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2415030","version":"1","preferredName":"Current Report Period Administered","preferredDefinition":"Occurring in or belonging to the present time.:Report; a short account.:An interval of time. (NCI):Given.","longName":"C25471:C25375:C25616:C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Current","conceptCode":"C25471","definition":"Occurring in or belonging to the present time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Report","conceptCode":"C25375","definition":"A short textual account; having provided a short account.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Period","conceptCode":"C25616","definition":"An interval of time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"027804FD-E41D-104C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-07","modifiedBy":"ONEDATA","dateModified":"2005-10-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"027804FD-E52B-104C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-07","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2415073","version":"1","preferredName":"Growth Factor Administered Type","preferredDefinition":"the type of growth factor administered.","longName":"GRWTHFAC_ADM_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"15","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"rhGM_CSF","valueDescription":"GM-CSF","ValueMeaning":{"publicId":"2576458","version":"1","preferredName":"GM-CSF","longName":"2576458","preferredDefinition":"Granulocyte-macrophage colony-stimulating factor. A colony-stimulating factor that stimulates the production of white blood cells, especially granulocytes and macrophages, and cells (in the bone marrow) that are precursors of platelets. It is a cytokine that belongs to the family of drugs called hematopoietic (blood-forming) agents. Also called sargramostim.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recombinant Granulocyte-Macrophage Colony-Stimulating Factor","conceptCode":"C1288","definition":"A recombinant therapeutic agent which is chemically identical to or similar to the endogenous glycoprotein cytokine growth factor granulocyte-macrophage colony stimulating factor (GM-CSF). Therapeutic GM-CSF induces the clonal expansion and differentiation of progenitor blood cells and stimulates the cytotoxicity of monocytes and neutrophils, thereby restoring immune function and host antitumor immune responses and stimulating engraftment of transplanted bone marrow tissue. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F7B7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-07","modifiedBy":"SHIDED","dateModified":"2013-05-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"027804FD-E55C-104C-E044-0003BA3F9857","beginDate":"2005-10-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-07","modifiedBy":"CAMPBELB","dateModified":"2005-10-07","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2559653","version":"1","preferredName":"Other","longName":"2559653","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B612-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0290511F-92B4-2465-E044-0003BA3F9857","beginDate":"2005-10-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-07","modifiedBy":"ONEDATA","dateModified":"2005-10-07","deletedIndicator":"No"},{"value":"G-CSF","valueDescription":"G-CSF","ValueMeaning":{"publicId":"2576459","version":"1","preferredName":"G-CSF","longName":"2576459","preferredDefinition":"Colony Stimulating Factor 3, encoded by the CSF3 gene, is a cytokine that controls the production, differentiation, and function of granulocytes. The active protein is found extracellularly. Three transcript variants encoding three different protein isoforms have been found for this gene. (From LocusLink)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Granulocyte Colony-Stimulating Factor","conceptCode":"C26078","definition":"Granulocyte colony-stimulating factor (207 aa, ~22 kDa) is encoded by the human CSF3 gene. This protein is involved in the regulation of the production, differentiation, and function of granulocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F7B8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-07","modifiedBy":"SHIDED","dateModified":"2013-05-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"029032CA-833B-23FF-E044-0003BA3F9857","beginDate":"2005-10-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-07","modifiedBy":"ONEDATA","dateModified":"2005-10-07","deletedIndicator":"No"},{"value":"Neumega","valueDescription":"Oprelvekin","ValueMeaning":{"publicId":"2664856","version":"1","preferredName":"Oprelvekin","longName":"2664856","preferredDefinition":"A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine interleukin 11 (IL-11). Secreted by bone marrow stromal cells and a number of mesenchymal cells, IL-11 binds to and activates its cell-surface receptor, promoting primary and secondary immune responses, modulating antigen-specific antibody reactions, and preventing apoptotic cell death.  This agent also stimulates the T-cell-dependent development of IgG-secreting B-cells in spleen cell cultures and may be an important regulator of megakaryocytopoiesis. (NCI04)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oprelvekin","conceptCode":"C1303","definition":"A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine interleukin 11 (IL-11). Secreted by bone marrow stromal cells and a number of mesenchymal cells, IL-11 binds to and activates its cell-surface receptor, promoting primary and secondary immune responses, modulating antigen-specific antibody reactions, and preventing apoptotic cell death.  This agent also stimulates the T-cell-dependent development of IgG-secreting B-cells in spleen cell cultures and may be an important regulator of megakaryocytopoiesis. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"35A00595-9C5C-3A15-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-19","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"35A00595-9C74-3A15-E044-0003BA3F9857","beginDate":"2007-07-19","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-19","modifiedBy":"CAMPBELB","dateModified":"2007-07-19","deletedIndicator":"No"},{"value":"Epoetin","valueDescription":"Epoetin Alfa","ValueMeaning":{"publicId":"2576817","version":"1","preferredName":"Epoetin Alfa","longName":"2576817","preferredDefinition":"A colony-stimulating factor that is made in the laboratory. It increases the production of red blood cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epoetin Alfa","conceptCode":"C2695","definition":"A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine human erythropoietin (EPO). Produced primarily by cells of the peritubular capillary endothelium of the kidney in response to hypoxia, circulating EPO binds to EPO receptors on the surface of committed erythroid progenitors in the bone marrow resulting in their replication and maturation into functional erythrocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F91E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-11-08","modifiedBy":"ONEDATA","dateModified":"2005-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"35A00CB8-5325-2770-E044-0003BA3F9857","beginDate":"2007-07-19","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-19","modifiedBy":"ONEDATA","dateModified":"2007-07-19","deletedIndicator":"No"},{"value":"Filgrastim","valueDescription":"Filgrastim","ValueMeaning":{"publicId":"2576855","version":"1","preferredName":"Filgrastim","longName":"2576855","preferredDefinition":"A colony-stimulating factor that stimulates the production of neutrophils (a type of white blood cell). It is a cytokine that belongs to the family of drugs called hematopoietic (blood-forming) agents. Also called granulocyte colony-stimulating factor (G-CSF).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Filgrastim","conceptCode":"C1474","definition":"A recombinant, non-glycosylated cytokine which is chemically identical to or similar to the endogenous cytokine human granulocyte colony-stimulating factor (G-CSF) isoform B, with immunomodulating activity. Filgrastim binds to and activates G-CSF receptors with the same biological activity and stability as the endogenous cytokine, thereby controlling the production, differentiation, and function of neutrophilic granulocyte progenitors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F944-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-11-08","modifiedBy":"ONEDATA","dateModified":"2005-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"52500CF3-92A9-1916-E044-0003BA3F9857","beginDate":"2008-07-18","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-07-18","modifiedBy":"ONEDATA","dateModified":"2008-07-18","deletedIndicator":"No"},{"value":"Sargramostim","valueDescription":"Sargramostim","ValueMeaning":{"publicId":"2767220","version":"1","preferredName":"Sargramostim","longName":"2767220","preferredDefinition":"Sargramostim","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"52500C0F-AA0B-1914-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-07-18","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-07-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"52500CF3-92BB-1916-E044-0003BA3F9857","beginDate":"2008-07-18","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-07-18","modifiedBy":"ONEDATA","dateModified":"2008-07-18","deletedIndicator":"No"},{"value":"GM-CSF","valueDescription":"GM-CSF","ValueMeaning":{"publicId":"2576458","version":"1","preferredName":"GM-CSF","longName":"2576458","preferredDefinition":"Granulocyte-macrophage colony-stimulating factor. A colony-stimulating factor that stimulates the production of white blood cells, especially granulocytes and macrophages, and cells (in the bone marrow) that are precursors of platelets. It is a cytokine that belongs to the family of drugs called hematopoietic (blood-forming) agents. Also called sargramostim.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recombinant Granulocyte-Macrophage Colony-Stimulating Factor","conceptCode":"C1288","definition":"A recombinant therapeutic agent which is chemically identical to or similar to the endogenous glycoprotein cytokine growth factor granulocyte-macrophage colony stimulating factor (GM-CSF). Therapeutic GM-CSF induces the clonal expansion and differentiation of progenitor blood cells and stimulates the cytotoxicity of monocytes and neutrophils, thereby restoring immune function and host antitumor immune responses and stimulating engraftment of transplanted bone marrow tissue. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F7B7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-07","modifiedBy":"SHIDED","dateModified":"2013-05-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCEF70CA-1C9D-11C6-E040-BB89AD433FC9","beginDate":"2013-05-17","endDate":null,"createdBy":"TSANE","dateCreated":"2013-05-17","modifiedBy":"ONEDATA","dateModified":"2013-05-17","deletedIndicator":"No"},{"value":"None","valueDescription":"None","ValueMeaning":{"publicId":"2577064","version":"1","preferredName":"None","longName":"2577064","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA15-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-22","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A9828F6-70B3-D6A9-E050-BB89AD431379","beginDate":"2014-12-19","endDate":null,"createdBy":"CORRALC","dateCreated":"2014-12-19","modifiedBy":"ONEDATA","dateModified":"2014-12-19","deletedIndicator":"No"},{"value":"Tbo Filgrastim","valueDescription":"Tbo Filgrastim","ValueMeaning":{"publicId":"4642691","version":"1","preferredName":"Tbo Filgrastim","longName":"4642691","preferredDefinition":"Tbo Filgrastim","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A9828F6-70BD-D6A9-E050-BB89AD431379","latestVersionIndicator":"Yes","beginDate":"2014-12-19","endDate":null,"createdBy":"CORRALC","dateCreated":"2014-12-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A9828F6-70D6-D6A9-E050-BB89AD431379","beginDate":"2014-12-19","endDate":null,"createdBy":"CORRALC","dateCreated":"2014-12-19","modifiedBy":"ONEDATA","dateModified":"2014-12-19","deletedIndicator":"No"},{"value":"Pegfilgrastim (Neulasta)","valueDescription":"Pegfilgrastim (Neulasta)","ValueMeaning":{"publicId":"4642692","version":"1","preferredName":"Pegfilgrastim (Neulasta)","longName":"4642692","preferredDefinition":"Pegfilgrastim (Neulasta)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A9828F6-70E0-D6A9-E050-BB89AD431379","latestVersionIndicator":"Yes","beginDate":"2014-12-19","endDate":null,"createdBy":"CORRALC","dateCreated":"2014-12-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A9828F6-70F9-D6A9-E050-BB89AD431379","beginDate":"2014-12-19","endDate":null,"createdBy":"CORRALC","dateCreated":"2014-12-19","modifiedBy":"ONEDATA","dateModified":"2014-12-19","deletedIndicator":"No"},{"value":"Filgrastim-sndz","valueDescription":"Filgrastim-sndz","ValueMeaning":{"publicId":"5837000","version":"1","preferredName":"Filgrastim-sndz","longName":"5837000","preferredDefinition":"A colony-stimulating factor that stimulates the production of neutrophils (a type of white blood cell). It is a cytokine that belongs to the family of drugs called hematopoietic (blood-forming) agents. It is a biosimilar injectable.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"502308AD-D3C5-3059-E053-F662850A0892","latestVersionIndicator":"Yes","beginDate":"2017-05-22","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2017-05-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"502308AD-D3DE-3059-E053-F662850A0892","beginDate":"2017-05-22","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2017-05-22","modifiedBy":"ONEDATA","dateModified":"2017-05-22","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"027804FD-E542-104C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-07","modifiedBy":"CAMPBELB","dateModified":"2017-05-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811835","version":"1","longName":"Melanoma","context":"CTEP"},{"publicId":"2811871","version":"1","longName":"Colorectal","context":"CTEP"},{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"},{"publicId":"2811908","version":"1","longName":"Gynecologic","context":"CTEP"},{"publicId":"2811909","version":"1","longName":"Leukemia","context":"CTEP"},{"publicId":"2811950","version":"1","longName":"Multiple Myeloma","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"}]},{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"If yes,","type":"Preferred Question Text","description":"If yes,","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Growth factor","url":null,"context":"CTEP"},{"name":"COG CRF Text_1","type":"Alternate Question Text","description":"Growth Factor Type","url":null,"context":"CTEP"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Growth Factor administered","url":null,"context":"CTEP"}],"origin":"SWOG CRF:Southwest Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"029032CA-830D-23FF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-07","modifiedBy":"CORRALC","dateModified":"2014-12-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}